Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 34% ± 14% | |
intestine | 7 studies | 31% ± 14% | |
brain | 7 studies | 29% ± 7% | |
eye | 7 studies | 24% ± 10% | |
peripheral blood | 5 studies | 23% ± 6% | |
kidney | 5 studies | 26% ± 9% | |
pancreas | 4 studies | 63% ± 18% | |
uterus | 4 studies | 38% ± 8% | |
breast | 4 studies | 33% ± 11% | |
liver | 4 studies | 29% ± 21% | |
placenta | 3 studies | 32% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4077.67 | 2642 / 2642 | 100% | 183.09 | 705 / 705 |
liver | 100% | 1371.67 | 226 / 226 | 100% | 167.76 | 406 / 406 |
skin | 100% | 2312.18 | 1809 / 1809 | 100% | 244.07 | 472 / 472 |
thymus | 100% | 2726.31 | 653 / 653 | 100% | 158.26 | 605 / 605 |
uterus | 100% | 3268.42 | 170 / 170 | 100% | 196.56 | 459 / 459 |
prostate | 100% | 3274.81 | 245 / 245 | 100% | 197.58 | 500 / 502 |
ovary | 100% | 3741.39 | 180 / 180 | 100% | 152.25 | 428 / 430 |
esophagus | 100% | 2434.47 | 1445 / 1445 | 99% | 91.67 | 182 / 183 |
pancreas | 100% | 1611.48 | 328 / 328 | 99% | 158.62 | 177 / 178 |
breast | 100% | 2989.18 | 459 / 459 | 99% | 229.09 | 1111 / 1118 |
stomach | 100% | 1701.91 | 359 / 359 | 99% | 121.41 | 284 / 286 |
bladder | 100% | 2774.67 | 21 / 21 | 99% | 169.51 | 500 / 504 |
lung | 99% | 2078.61 | 575 / 578 | 100% | 158.71 | 1150 / 1155 |
intestine | 100% | 2092.12 | 966 / 966 | 99% | 141.71 | 521 / 527 |
adrenal gland | 100% | 2206.84 | 258 / 258 | 99% | 210.65 | 227 / 230 |
kidney | 100% | 2678.15 | 89 / 89 | 98% | 139.40 | 880 / 901 |
adipose | 100% | 2767.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 375.96 | 80 / 80 |
heart | 100% | 3404.94 | 861 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 139.79 | 29 / 29 |
spleen | 100% | 1426.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 126.84 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 198.04 | 1 / 1 |
blood vessel | 100% | 3634.93 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2464.75 | 801 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 45% | 467.56 | 417 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032099 | Biological process | negative regulation of appetite |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0000165 | Biological process | MAPK cascade |
GO_0005615 | Cellular component | extracellular space |
GO_0012505 | Cellular component | endomembrane system |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0008083 | Molecular function | growth factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NENF |
Protein name | Neudesin (Cell immortalization-related protein 2) (Neuron-derived neurotrophic factor) (Protein GIG47) (Secreted protein of unknown function) (SPUF protein) |
Synonyms | SPUF CIR2 |
Description | FUNCTION: Acts as a neurotrophic factor in postnatal mature neurons enhancing neuronal survival . Promotes cell proliferation and neurogenesis in undifferentiated neural progenitor cells at the embryonic stage and inhibits differentiation of astrocytes (By similarity). Its neurotrophic activity is exerted via MAPK1/ERK2, MAPK3/ERK1 and AKT1/AKT pathways (By similarity). Neurotrophic activity is enhanced by binding to heme (By similarity). Acts also as an anorexigenic neurotrophic factor that contributes to energy balance (By similarity). . |
Accessions | ENST00000366988.5 Q9UMX5 |